The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
Open accessAbstract
Elevated expression of polo-like kinase1 (Plk1) has been reported in many human tumors, and inhibition of Plk1 activity results in their mitotic arrest and apoptosis. Here we describe the profile of ON01910, a small molecule inhibitor of Plk1 activity, which induces mitotic arrest of tumor cells characterized by spindle abnormalities leading to their apoptosis. This compound was not ATP-competitive, but competed for the substrate binding site of the enzyme. In vivo, this compound did not exhibit hematotoxicity, liver damage, or neurotoxicity, and was a potent inhibitor of tumor growth in a variety of xenograft nude mouse models. ON01910 showed strong synergy with several chemotherapeutic agents, often inducing complete regression of tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · cited 1×
“Cell cycle progression is orchestrated by Cyclin/CDK complexes, which are formed at specific stages of the cell cycle, and whose activities are required for progression through S phase and mitosis (Malumbres and Barbacid, 2001; Sherr and McCormick, 2002; Blagosklonny and Pardee, 2003).”
BackgroundTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Polo-like kinases and the orchestration of cell division
Barr, F. A., Silljé, H. H. W., & Nigg, E. A. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1401 · Cited by 1,087
The National Cancer Institute: cancer drug discovery and development program.
Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992) · PubMed · Cited by 722
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
Soldani, C., & Scovassi, A. I. (2002) · Apoptosis · doi:10.1023/a:1016119328968 · Cited by 697
Lane, H. A., & Nigg, E. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1701 · Cited by 690
Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles
Sunkel, C. E., & Glover, D. M. (1988) · Journal of Cell Science · doi:10.1242/jcs.89.1.25 · Cited by 561
Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts
Kumagai, A., & Dunphy, W. G. (1996) · Science · doi:10.1126/science.273.5280.1377 · Cited by 507
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
Heintz, N., Sive, H. L., & Roeder, R. G. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.4.539 · Cited by 470
Polo-like kinases: a team that plays throughout mitosis
Glover, D. M., Hagan, I. M., & Tavares, Á. A. M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3777 · Cited by 424
The Restriction Point of the Cell Cycle
Blagosklonny, M. V., & Pardee, A. B. (2002) · Cell Cycle · doi:10.4161/cc.1.2.108 · Cited by 412
Ohkura, H., Hagan, I. M., & Glover, D. M. (1995) · Genes & Development · doi:10.1101/gad.9.9.1059 · Cited by 371
Roles of Polo-like Kinase 1 in the Assembly of Functional Mitotic Spindles
Sumara, I., Giménez-Abián, J. F., Gerlich, D., Hirota, T., Kraft, C., de la Torre, C., Ellenberg, J., & Peters, J.-M. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.049 · Cited by 345
Polo-like kinases: positive regulators of cell division from start to finish
Nigg, E. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80121-x · Cited by 344
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 327
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
Wolf, G., Elez, R., Doermer, A., Holtrich, U., Ackermann, H., Stutte, H. J., Altmannsberger, H.-M., Rübsamen-Waigmann, H., & Strebhardt, K. (1997) · Oncogene · doi:10.1038/sj.onc.1200862 · Cited by 323
Kotani, S., Tugendreich, S., Fujii, M., Jorgensen, P.-M., Watanabe, N., Hoog, C., Hieter, P., & Todokoro, K. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80037-4 · Cited by 304
Golsteyn, R. M., Schultz, S. J., Bartek, J., Ziemiecki, A., Ried, T., & Nigg, E. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.6.1509 · Cited by 278
Kitada, K., Johnson, A. L., Johnston, L. H., & Sugino, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4445 · Cited by 263
Smith, M. R., Wilson, M. L., Hamanaka, R., Chase, D., Kung, H.-F., Longo, D. L., & Ferris, D. K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6633 · Cited by 248
Knecht, R., Elez, R., Oechler, M., Solbach, C., von Ilberg, C., & Strebhardt, K. (1999) · PubMed · Cited by 232
Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents
Levitzki, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00066-7 · Cited by 214
Harker, W. G., & Sikic, B. I. (1985) · PubMed · Cited by 209
Identification of an early-growth-response gene encoding a novel putative protein kinase.
Simmons, D. L., Neel, B. G., Stevens, R., Evett, G., & Erikson, R. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4164 · Cited by 194
Donohue, P. J., Alberts, G. F., Guo, Y., & Winkles, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10351 · Cited by 191
Lee, K. S., & Erikson, R. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3408 · Cited by 180
Opportunities and challenges in the development of kinase inhibitor therapy for cancer
Sawyers, C. L. (2003) · Genes & Development · doi:10.1101/gad.1152403 · Cited by 170
Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis
Hamanaka, R., Smith, M. R., O'Connor, P. M., Maloid, S., Mihalic, K., Spivak, J. L., Longo, D. L., & Ferris, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21086 · Cited by 164
Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., & Pommier, Y. G. (1995) · PubMed · Cited by 151
Spänkuch, B., Wolf, G., Solbach, C., Loibl, S., Knecht, R., Stegmüller, M., von Minckwitz, G., Kaufmann, M., & Strebhardt, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205412 · Cited by 149
Li, B., Ouyang, B., Pan, H., Reissmann, P. T., Slamon, D. J., Arceci, R. J., Lu, L., & Dai, W. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19402 · Cited by 145
Prognostic significance of polo-like kinase expression in esophageal carcinoma.
Tokumitsu, Y., Mori, M., Tanaka, S., Akazawa, K., Nakano, S., & Niho, Y. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.4.687 · Cited by 134
Takai, N., Miyazaki, T., Fujisawa, K., Nasu, K., Hamanaka, R., & Miyakawa, I. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00703-5 · Cited by 111
Schuurmans, C. J., Motro, B., Yousefi, S., Heffernan, M. J., & Dennis, J. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6388 · Cited by 101
Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
Cogswell, J. P., Brown, C. E., Bisi, J., & Neill, S. D. (2000) · PubMed · Cited by 101
Polo kinase: the choreographer of the mitotic stage?
Glover, D. M., Ohkura, H., & Tavares, Á. A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.6.1681 · Cited by 96
Polo-like kinases in the nervous system
Seeburg, D. P., Pak, D. T. S., & Sheng, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208277 · Cited by 95
Lake, R. J., & Jelinek, W. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7793-7801.1993 · Cited by 93
Polo kinase and progression through M phase in Drosophila: a perspective from the spindle poles
Glover, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208279 · Cited by 84
Conn, C. W., Hennigan, R. F., Dai, W. H., Sánchez, Y., & Stambrook, P. J. (2000) · PubMed · Cited by 81
Centrosome duplication: Three kinases come up a winner!
Hinchcliffe, E. H., & Sluder, G. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00412-2 · Cited by 43
Cloning and Characterization of Plx2 and Plx3, Two Additional Polo-like Kinases from Xenopus laevis
Duncan, P. I., Pollet, N., Niehrs, C., & Nigg, E. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5333 · Cited by 37
Polo-like kinases and the microtubule organization center: targets for cancer therapies.
Dai, W. H., & Cogswell, J. P. (2003) · PubMed · Cited by 29
Caenorhabditis ElegansContains Structural Homologs of Humanprkandplk
Ouyang, B., Wang, Y., & Dai, W. H. (1999) · DNA sequence · doi:10.3109/10425179909008427 · Cited by 27
Protein Tyrosine Kinase Inhibitors as Therapeutic Agents
Levitzki, A. (2000) · Topics in current chemistry · doi:10.1007/3-540-45035-1_1 · Cited by 16
Cited by
Targeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Kinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Metadata
- Authors
- Gumireddy, K., Reddy, M. V. R., Cosenza, S. C., Nathan, R. B., Baker, S. J., Papathi, N., Jiang, J., Holland, J., & Reddy, E. P.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 7
- Issue
- 3
- Pages
- 275-286
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1976023782
- Cited by
- 367
- References
- 48
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.